✦ LIBER ✦

Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study

✍ Scribed by David J Moliterno; Steven J Yakubov; Peter M DiBattiste; Howard C Herrmann; Gregg W Stone; Carlos Macaya; Franz-Josef Neumann; Diego Ardissino; Jean-Pierre Bassand; Lynn Borzi; Alan C Yeung; Katherine A Harris; Laura A Demopoulos; Eric J Topol

Book ID: 117281306
Publisher: The Lancet
Year: 2002
Tongue: English
Weight: 100 KB
Volume: 360
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(02)09605-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A direct comparison of tirofiban and abc

A direct comparison of tirofiban and abciximab during percutaneous coronary revascularization and stent placement: Rationale and design of the TARGET study

✍ David J. Moliterno; Eric J. Topol; for the TARGET International Steering Committ 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 76 KB

A randomized two-by-two comparison of hi

A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: The tirofiban evaluation of novel dosing versus abciximab with clopidogrel and inhibition of thrombin (TENACITY) study trial

✍ David J. Moliterno;; the TENACITY Steering Committee; Investigators 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 1 views